Third Primary SARS-CoV-2 mRNA Vaccines Enhance Antibody Responses in Most Patients with Haematological Malignancies

The MARCH database is a retrospective observational study of serological responses in patients with blood disorders. Scientists presented data on 381 patients with hematological malignancies.